C9orf64 has been reported as an epigenetic biomarker that distinguishes patients with NSCLC from those with nonmalignant lung disease at the transcriptional level (29) and has a higher level of methylation in ovarian cancer (30). The gene discussed is QNG1; the disease is ovarian cancer.